Ghanaian public health researcher Gifty Aboagye-Mensah is making significant strides in the field of international academia, ...

Palvella Therapeutics Inc. Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the ...

The Texas Public Health Association will hold its 101st annual conference May 13 to 15 at t Events Center. The conference, titled "Launching into the Future of Public Health: On the Border, By the Sea ...

MSD Vietnam, in collaboration with the Vietnam Association of Preventive Medicine (VAPM), recently organized the HPV Summit ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data from its Phase 2a clinical ...

Today on Louisiana Considered, we hear about LSU’s new nursing program in Baton Rouge and dive into the history of trade wars ...

Inclusive, culturally safe’ care for LGBTQIA+ patients means more than just rainbow posters in the waiting room.

A Master of Public Health (MPH) student at The Brown School of Washington University in St Louis, Missouri, Ms Aboagye-Mensah ...

Prostatectomy for grade group 1 prostate cancer significantly decreased from 2010 to 2024 in SEER and MUSIC data. Remaining ...

Detailed price information for Atyr Pharma Inc (ATYR-Q) from The Globe and Mail including charting and trades.

Recommendation based on AMPLIFY Phase III trial which showed Calquencecombinations demonstrated statistically significant and clinically meaningfulimprovement in progression-free survival vs.

Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced that an abstract presenting groundbreaking data on the prevalence and annual incidence of lymphatic malformations (LMs) in the U.S. has been ...